Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/01/2026 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.57B | 1.43B | 1.22B | 1.13B | 1.07B | 942M |
| Cost of revenue | 879M | 802M | 716M | 673M | 600M | 538M |
| Gross profit | 692M | 626M | 503M | 453M | 472M | 404M |
| Research and development | 238M | 221M | 212M | 215M | 193M | 189M |
| Selling, general and administrative | 61M | 59M | 61M | 57M | 54M | 58M |
| Operating expenses | 454M | 436M | 430M | 420M | 391M | 377M |
| Operating income | 238M | 189M | 74M | 33M | 81M | 27M |
| Pre-tax income | 231M | 181M | 66M | 19M | 69M | 16M |
| Income tax | 13M | 31M | 16M | 10M | 24M | 2M |
| Net income | 218M | 150M | 50M | 9M | 45M | 14M |
| Earnings per share | 1.54 | 1.06 | 0.35 | 0.06 | 0.31 | 0.10 |
| Earnings per share, diluted | 1.49 | 1.03 | 0.35 | 0.06 | 0.31 | 0.10 |
| Weighted average shares | 142M | 142M | 142M | 143M | 143M | 144M |
| Weighted average shares, diluted | 146M | 146M | 144M | 145M | 146M | 145M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.05B | 1.12B | 1.09B | 1.06B | 950M | 875M | 935M | 884M |
| Short-term investments | 158M | 176M | 216M |
| Metric | 30/04/2026 | 31/01/2026 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | 228M | — | — | 104M | — |
| Depreciation and amortisation | — | 32M | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 270M |
| 304M |
| 337M |
| 316M |
| 218M |
| Receivables | 1.05B | 967M | 976M | 1.03B | 930M | 939M | 909M | 900M |
| Inventory | 808M | 846M | 826M | 860M | 874M | 845M | 820M | 937M |
| Current assets | 3.57B | 3.54B | 3.57B | 3.69B | 3.56B | 3.49B | 3.54B | 3.54B |
| Goodwill | 520M | 522M | 521M | 445M | 445M | 444M | 445M | 445M |
| Total assets | 6.04B | 5.89B | 5.86B | 5.75B | 5.66B | 5.57B | 5.64B | 5.58B |
| Current liabilities | 1.31B | 1.26B | 1.31B | 1.12B | 1.05B | 957M | 1B | 871M |
| Short-term debt | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M |
| Long-term debt | 1.52B | 1.52B | 1.52B | 1.53B | 1.53B | 1.53B | 1.53B | 1.54B |
| Total liabilities | 3.15B | 3.10B | 3.14B | 2.96B | 2.88B | 2.78B | 2.83B | 2.68B |
| Equity | 2.89B | 2.79B | 2.73B | 2.79B | 2.78B | 2.79B | 2.82B | 2.89B |
| Shares outstanding | 142M | 141M | 141M | 141M | 142M | 143M | 143M | 144M |
| Shares issued | 142M | 141M | 141M | 141M | 142M | 143M | 143M | 144M |
| 25M |
| — |
| Share-based compensation | 55M | 50M | 47M | 48M | 41M | 37M |
| Capital expenditure | — | 74M | — | — | 27M | — |
| Investing cash flow | — | −44M | — | — | −67M | — |
| Share buybacks | — | 81M | — | — | 81M | — |
| Financing cash flow | — | −155M | — | — | −93M | — |